• Tuesday, September 1, 2020 @ 12:00 am

Santersus AG (Switzerland), a privately held innovative plasmapheresis start-up company, has closed a CHF 750 thousand post-seed funding round. “The Company intends to use the net proceeds for the clinical and regulatory development,” said Scott Maguire, the chairman of Santersus AG.

You may also be interested in